Literature DB >> 7678625

Multiple changes in VLA protein glycosylation, expression, and function occur during mouse T cell ontogeny.

S Wadsworth1, M J Halvorson, A C Chang, J E Coligan.   

Abstract

VLA molecules (beta 1 integrins) are cell-surface alpha beta heterodimers that bind to extracellular matrix (ECM) proteins such as fibronectin, laminin, and collagen. We analyzed the expression, structure, and function of VLAs on mouse thymocytes, as a first step toward understanding their role in T cell development. Two major forms of beta 1 were detected, which differed in their extent of N-glycosylation and sialylation. No evidence for alternative splicing of beta 1 mRNA was obtained by PCR analyses. The larger (135 kDa, nonreduced) more basic beta 1 was the only form on nonmature (J11d+) adult thymocytes, with 135 kDa and larger beta 1-chains expressed on fetal thymocytes from day 14 of gestation through birth. The smaller (120 kDa, nonreduced), more acidic beta-chain was found exclusively on mature (J11d-) thymocytes and peripheral lymphocytes. VLA alpha-chain expression was also analyzed. Virtually all thymocytes were VLA-alpha 4+, -alpha 6+. VLA-alpha 5 was detected in both J11d+ and J11d- thymocytes by immunoprecipitation, but could not be analyzed in detail because of the lack of an appropriate mAb for flow cytometry. VLA-alpha 1 and -alpha 2 were immunoprecipitated only from cells within the J11d- population. Only J11d+ thymocytes (12 to 15%) bound to fibronectin (via VLA-4 and VLA-5) and binding to laminin (via VLA-6) was two to fourfold higher in J11d+ compared with J11d- thymocytes (60 to 80% vs 20 to 30%). The high percentage of J11d+ thymocytes adhering to laminin suggests that VLA-6 exists in an activated state on most thymocytes, in contrast to resting peripheral T cells. These data show that major changes in VLA glycosylation, expression, and ECM-binding capacity occur as thymocytes mature, supporting the hypothesis that VLA-ECM interactions play a role in T cell ontogeny.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678625

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin beta1.

Authors:  Xiaoyan Shen; Myoung-Soon Hong; Joel Moss; Martha Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

2.  Hepatic regulation of lymphocyte adhesion to, and activation on, syngeneic endothelial monolayers.

Authors:  R M Gorczynski; Z Cohen; X M Fu; G Levy; H Plapler; B Sullivan
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

3.  The Role of the T lymphocytes and Remodeling in Asthma.

Authors:  Kawa Amin
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

4.  Lipopolysaccharide induced upregulation of beta-1,4-galactosyltransferase-I in Schwann cell.

Authors:  Huiguang Yang; Ling Hu; Jianping Chen; Jianchun Zhu; Tao Tao; Fupeng Zhang; Xiaohong Li; Xingxin He; Aiguo Shen; Chun Cheng
Journal:  Inflammation       Date:  2009-10       Impact factor: 4.092

5.  An essential role for thymic mesenchyme in early T cell development.

Authors:  R K Suniara; E J Jenkinson; J J Owen
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

6.  Laminin 5 in the human thymus: control of T cell proliferation via alpha6beta4 integrins.

Authors:  M Vivinus-Nebot; M Ticchioni; F Mary; P Hofman; V Quaranta; P Rousselle; A Bernard
Journal:  J Cell Biol       Date:  1999-02-08       Impact factor: 10.539

7.  Expression of a beta 1-related integrin by oligodendroglia in primary culture: evidence for a functional role in myelination.

Authors:  S Malek-Hedayat; L H Rome
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

8.  The alpha 4 integrin chain is a ligand for alpha 4 beta 7 and alpha 4 beta 1.

Authors:  P Altevogt; M Hubbe; M Ruppert; J Lohr; P von Hoegen; M Sammar; D P Andrew; L McEvoy; M J Humphries; E C Butcher
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.